Study Identifies Elevated Isthmin-1 Levels as Indicator of Renal Function Decline in Type 2 Diabetes

A recent study has identified isthmin-1 as a potential biomarker associated with the progression of renal function decline in individuals with type 2 diabetes mellitus. The research, published in *BMC Endocrine Disorders*, highlights that elevated serum levels of isthmin-1 may serve as an important indicator for monitoring kidney health in diabetic patients.

The study provides evidence linking high concentrations of isthmin-1 in the blood to worsening renal function among those with type 2 diabetes. Researchers suggest that this discovery could help healthcare providers better assess and track kidney-related complications in diabetic patients. The findings contribute to ongoing efforts to improve early detection and management strategies for diabetes-related kidney disease.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

Related posts:

Biopharma Intelligence Shifts: Industry Accesses Raw Data Platforms for Unfiltered Insights. Alvotech and Dr. Reddy’s Partner to Develop Biosimilar for Cancer Drug Pembrolizumab Updated Guidelines Recommend SGLT-2 Inhibitors and GLP-1 Agonists for Cardiovascular and Kidney Benefits in Type 2 Diabetes Twin Study Reveals Genetic Role in Social Media Use and Mental Health Connection

Author

GOAI